Yaron Werber
Stock Analyst at TD Cowen
(2.54)
# 2,190
Out of 5,152 analysts
43
Total ratings
46.88%
Success rate
4.04%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yaron Werber
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LEGN Legend Biotech | Downgrades: Hold | $62 → $21 | $17.75 | +18.31% | 3 | Jan 22, 2026 | |
| VOR Vor Biopharma | Initiates: Buy | n/a | $14.56 | - | 1 | Dec 17, 2025 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $86 → $75 | $21.46 | +249.49% | 3 | Nov 5, 2025 | |
| EXEL Exelixis | Maintains: Buy | $44 → $51 | $41.28 | +23.55% | 3 | Nov 5, 2025 | |
| ARGX argenx SE | Maintains: Buy | $800 → $1,146 | $728.11 | +57.39% | 4 | Oct 31, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $59 → $99 | $75.16 | +31.72% | 2 | Oct 30, 2025 | |
| ALEC Alector | Downgrades: Hold | n/a | $2.00 | - | 1 | Oct 22, 2025 | |
| IOBT IO Biotech | Downgrades: Hold | n/a | $0.33 | - | 2 | Sep 30, 2025 | |
| ONC BeOne Medicines AG | Reiterates: Buy | $334 | $292.94 | +14.02% | 1 | Apr 24, 2025 | |
| FBRX Forte Biosciences | Initiates: Buy | n/a | $30.28 | - | 1 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $61.43 | - | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $27.47 | - | 1 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $153 | $237.35 | -35.54% | 5 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $132 → $122 | $101.95 | +19.67% | 5 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $7.67 | - | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $34.65 | - | 1 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.37 | - | 1 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $4.98 | - | 2 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $29.36 | - | 1 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $8.53 | - | 2 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $38 | $27.48 | +38.28% | 1 | May 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $29.72 | - | 1 | Oct 26, 2021 |
Legend Biotech
Jan 22, 2026
Downgrades: Hold
Price Target: $62 → $21
Current: $17.75
Upside: +18.31%
Vor Biopharma
Dec 17, 2025
Initiates: Buy
Price Target: n/a
Current: $14.56
Upside: -
Ultragenyx Pharmaceutical
Nov 5, 2025
Maintains: Buy
Price Target: $86 → $75
Current: $21.46
Upside: +249.49%
Exelixis
Nov 5, 2025
Maintains: Buy
Price Target: $44 → $51
Current: $41.28
Upside: +23.55%
argenx SE
Oct 31, 2025
Maintains: Buy
Price Target: $800 → $1,146
Current: $728.11
Upside: +57.39%
Ionis Pharmaceuticals
Oct 30, 2025
Maintains: Buy
Price Target: $59 → $99
Current: $75.16
Upside: +31.72%
Alector
Oct 22, 2025
Downgrades: Hold
Price Target: n/a
Current: $2.00
Upside: -
IO Biotech
Sep 30, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.33
Upside: -
BeOne Medicines AG
Apr 24, 2025
Reiterates: Buy
Price Target: $334
Current: $292.94
Upside: +14.02%
Forte Biosciences
Jan 21, 2025
Initiates: Buy
Price Target: n/a
Current: $30.28
Upside: -
Dec 20, 2024
Initiates: Buy
Price Target: n/a
Current: $61.43
Upside: -
Nov 19, 2024
Initiates: Buy
Price Target: n/a
Current: $27.47
Upside: -
Nov 15, 2024
Maintains: Buy
Price Target: $160 → $153
Current: $237.35
Upside: -35.54%
Nov 6, 2024
Maintains: Hold
Price Target: $132 → $122
Current: $101.95
Upside: +19.67%
Nov 5, 2024
Initiates: Buy
Price Target: n/a
Current: $7.67
Upside: -
Mar 26, 2024
Upgrades: Buy
Price Target: n/a
Current: $34.65
Upside: -
Mar 18, 2024
Initiates: Outperform
Price Target: n/a
Current: $1.37
Upside: -
Mar 15, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $4.98
Upside: -
Dec 20, 2023
Initiates: Outperform
Price Target: n/a
Current: $29.36
Upside: -
Nov 1, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $8.53
Upside: -
May 2, 2022
Initiates: Market Perform
Price Target: $38
Current: $27.48
Upside: +38.28%
Oct 26, 2021
Initiates: Outperform
Price Target: n/a
Current: $29.72
Upside: -